TLDR Female pattern hair loss may indicate metabolic issues and increased cardiovascular risk.
This systematic review explores the link between Female Androgenetic Alopecia (FAGA) and Metabolic Syndrome (MS), analyzing 29 studies. It finds that 89% of the studies report a higher prevalence of MS or its components in women with FAGA, suggesting a strong association. However, some studies from Saudi Arabia, Egypt, and China did not find significant associations. The review suggests that FAGA could be a marker for metabolic abnormalities and increased cardiovascular risk, recommending healthcare providers screen for MS in women with FAGA, especially those with a family history of metabolic or cardiovascular issues. Further prospective studies are needed to better understand this relationship.
14 citations
,
January 2018 in “Advances in Clinical Chemistry” The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.
1 citations
,
September 2021 in “Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria” Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.
43 citations
,
November 2019 in “American Journal of Clinical Dermatology” FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.
1 citations
,
July 2017 in “Clinical research in dermatology” Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.
16 citations
,
September 2018 in “Journal of Ethnopharmacology” Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.
